Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 279

1.

Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences.

Playford EG, Craig JC, Iredell JR.

J Hosp Infect. 2007 Mar;65(3):204-11. Epub 2007 Jan 23.

PMID:
17254667
2.

Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.

Baran G, Erbay A, Bodur H, Ongürü P, Akinci E, Balaban N, Cevik MA.

Int J Infect Dis. 2008 Jan;12(1):16-21. Epub 2007 May 21.

3.

Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.

Routsi C, Pratikaki M, Platsouka E, Sotiropoulou C, Nanas S, Markaki V, Vrettou C, Paniara O, Giamarellou H, Roussos C.

Infection. 2010 Jun;38(3):173-80. doi: 10.1007/s15010-010-0008-1. Epub 2010 Mar 12.

PMID:
20224962
4.

Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre.

Kohlenberg A, Brümmer S, Higgins PG, Sohr D, Piening BC, de Grahl C, Halle E, Rüden H, Seifert H.

J Med Microbiol. 2009 Nov;58(Pt 11):1499-507. doi: 10.1099/jmm.0.012302-0. Epub 2009 Jul 9.

PMID:
19589905
5.

Outbreak of resistant Acinetobacter baumannii- measures and proposal for prevention and control.

Romanelli RM, Jesus LA, Clemente WT, Lima SS, Rezende EM, Coutinho RL, Moreira RL, Neves FA, Brás Nde J.

Braz J Infect Dis. 2009 Oct;13(5):341-7. doi: 10.1590/S1413-86702009000500005.

6.

Evaluation of Acinetobacter baumannii infection and colonization, and antimicrobial treatment patterns in an urban teaching hospital.

Weingarten CM, Rybak MJ, Jahns BE, Stevenson JG, Brown WJ, Levine DP.

Pharmacotherapy. 1999 Sep;19(9):1080-5.

PMID:
10610015
7.

An outbreak of imipenem-resistant Acinetobacter baumannii at Songklanagarind Hospital: the risk factors and patient prognosis.

Jamulitrat S, Thongpiyapoom S, Suwalak N.

J Med Assoc Thai. 2007 Oct;90(10):2181-91.

PMID:
18041440
8.

Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland.

Wroblewska MM, Towner KJ, Marchel H, Luczak M.

Clin Microbiol Infect. 2007 May;13(5):490-6. Epub 2007 Feb 28.

9.

Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: A case-control study.

Katragkou A, Kotsiou M, Antachopoulos C, Benos A, Sofianou D, Tamiolaki M, Roilides E.

Intensive Care Med. 2006 Sep;32(9):1384-91. Epub 2006 Jun 21.

PMID:
16788807
10.

Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients.

García-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jiménez-Jiménez FJ, Monterrubio-Villar J, Gili-Miner M.

Crit Care Med. 1999 Sep;27(9):1794-9.

PMID:
10507600
11.

Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex.

Tacconelli E, Cataldo MA, De Pascale G, Manno D, Spanu T, Cambieri A, Antonelli M, Sanguinetti M, Fadda G, Cauda R.

J Antimicrob Chemother. 2008 Nov;62(5):1130-7. doi: 10.1093/jac/dkn289. Epub 2008 Jul 17.

PMID:
18635519
12.

Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study.

Jang TN, Lee SH, Huang CH, Lee CL, Chen WY.

J Hosp Infect. 2009 Oct;73(2):143-50. doi: 10.1016/j.jhin.2009.06.007. Epub 2009 Aug 27.

PMID:
19716203
13.

Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit.

Holloway KP, Rouphael NG, Wells JB, King MD, Blumberg HM.

Ann Pharmacother. 2006 Nov;40(11):1939-45. Epub 2006 Oct 3.

PMID:
17018688
14.

A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.

Sheng WH, Liao CH, Lauderdale TL, Ko WC, Chen YS, Liu JW, Lau YJ, Wang LH, Liu KS, Tsai TY, Lin SY, Hsu MS, Hsu LY, Chang SC.

Int J Infect Dis. 2010 Sep;14(9):e764-9. doi: 10.1016/j.ijid.2010.02.2254. Epub 2010 Jun 19.

15.
16.

Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.

Jamal W, Salama M, Dehrab N, Al Hashem G, Shahin M, Rotimi VO.

J Hosp Infect. 2009 Jul;72(3):234-42. doi: 10.1016/j.jhin.2009.03.023. Epub 2009 Jun 3.

PMID:
19493588
17.

Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.

Anunnatsiri S, Tonsawan P.

Southeast Asian J Trop Med Public Health. 2011 May;42(3):693-703.

PMID:
21706949
18.

Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study.

García-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jiménez-Jiménez FJ, Pérez-Paredes C, Barrero-Almodóvar AE, Gili-Miner M.

Clin Infect Dis. 2001 Oct 1;33(7):939-46. Epub 2001 Aug 22.

PMID:
11528563
19.

[Multidrug-resistant Acinetobacter baumannii infection in respiratory intensive care unit].

Bacakoğlu F, Korkmaz Ekren P, Taşbakan MS, Başarik B, Pullukçu H, Aydemir S, Gürgün A, Başoğlu OK.

Mikrobiyol Bul. 2009 Oct;43(4):575-85. Turkish.

PMID:
20084910
20.

Association between antibiotic usage and subsequent colonization or infection of extensive drug-resistant Acinetobacter baumannii: a matched case-control study in intensive care units.

Tsai HT, Wang JT, Chen CJ, Chang SC.

Diagn Microbiol Infect Dis. 2008 Nov;62(3):298-305. doi: 10.1016/j.diagmicrobio.2008.06.017. Epub 2008 Aug 15.

PMID:
18707839

Supplemental Content

Support Center